Alzheimer's drug vs. brain exercises: which works better?
NCT ID NCT04661280
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two approaches for treating newly diagnosed Alzheimer's disease: the drug donepezil versus a non-drug approach using cognitive stimulation or remediation. Researchers will measure changes in thinking and memory over 6 months in 240 participants aged 50 and older. The goal is to see which method better eases symptoms of early Alzheimer's.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE, EARLY ONSET are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cognitive Neurology Center
RECRUITINGParis, 75010, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sound waves may help clear Alzheimer's brain clogs
- Zapping the brain to fight Alzheimer's: new trial launches
- Can a gentle brain zapping boost memory and mood in early dementia?
- Could flickering lights and sounds slow Alzheimer's? MIT launches home device trial
- Could magnetic pulses sharpen memory in early Alzheimer's?
- New brain scan could spot Alzheimer's years earlier